FGL2 and animal viral hepatitis: Based on these studies we postulated that interference with the FGL2-FCγRIIB inhibitory pathway would enhance anti-viral immune innate and adaptive immune responses in the experimental model of acute viral hepatitis caused by LCMV-WE.